Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000936392-09-000104
Filing Date
2009-03-03
Accepted
2009-03-02 20:17:30
Documents
7
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K a51249e10vk.htm 10-K 683201
2 EX-10.5 a51249exv10w5.htm EX-10.5 7835
3 EX-23.1 a51249exv23w1.htm EX-23.1 3171
4 EX-31.1 a51249exv31w1.htm EX-31.1 8121
5 EX-31.2 a51249exv31w2.htm EX-31.2 8473
6 EX-32.1 a51249exv32w1.htm EX-32.1 3581
7 GRAPHIC a51249a5124901.gif GRAPHIC 8362
  Complete submission text file 0000936392-09-000104.txt   727411
Mailing Address 3115 MERRYFIELD ROW SAN DIEGO CA 92121
Business Address 3115 MERRYFIELD ROW SAN DIEGO CA 92121 8585303600
ANADYS PHARMACEUTICALS INC (Filer) CIK: 0001128495 (see all company filings)

EIN.: 223193172 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-50632 | Film No.: 09649490
SIC: 2834 Pharmaceutical Preparations